TENAX THERAPEUTICS, INC. Assets, Fair Value Disclosure
TENAX THERAPEUTICS, INC. (TENX) had Assets, Fair Value Disclosure of $462.69 thousand as of 2020-12-31, per its 10-K/A filed 2021-04-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:AssetsFairValueDisclosure · last filed 2021-04-16
- 2020-12-31: Assets, Fair Value Disclosure $462.69K.
- 2019-12-31: Assets, Fair Value Disclosure $493.88K.
- 2018-12-31: Assets, Fair Value Disclosure $494.63K.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2020-12-31 | $462.69K 10-K/A · filed 2021-04-16 |
| 2019-12-31 | $493.88K 10-K · filed 2020-03-30 |
| 2018-12-31 | $494.63K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |